Clinical Trial Update: Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly [Phase 4]

View source ↗

Summary

Phase 4 trial update on Abraxane plus Carboplatin for advanced non-small cell lung cancer in the elderly; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Celgene | Conditions: Non-Small Cell Lung Cancer, Carcinoma | Phase 4 | Status: COMPLETED | Results posted: 2018-09-24